Latest News

Cancer drugs block dementia-linked brain inflammation, study finds

A class of drugs developed to treat immune-related conditions and cancer -- including one currently in clinical trials for glioblastoma and other tumors -- eliminates neural inflammation associated with dementia-linked diseases and brain injuries, according to researchers. In their study, the researchers discovered that the drugs, which can be delivered orally, eradicated microglia, the primary immune cells of the brain. These cells exacerbate many neural diseases, including Alzheimer's and Parkinson's, as well as brain injury.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Reviving drugs with anti-stroke potential, minus side effects

  • Shake it off? Not so easy for people with depression, new brain research suggests

  • Protein pathway involved in brain tumor stem cell growth identified

  • Enhancing studies on a possible blood biomarker for traumatic brain injury

  • Left or right? The brain knows before you move

  • Study challenges theory on unconscious memory system in the brain

  • Study challenges theory on unconscious memory system

  • Retinal swelling in premature infants tied to poorer neuro-development

  • Intermediary neuron acts as synaptic cloaking device

  • Method for mapping neuron clusters developed

  •